Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA
Myrlene S Aigbogun,1 Sizhu Liu,2 Siddhesh A Kamat,1 Christophe Sapin,3 Amy M Duhig,2 Leslie Citrome4 1Health Economics and Outcomes Research, Otsuka Pharmaceutical Development and Commercialization, Inc, Princeton, NJ, USA; 2Global Health Economics and Outcomes Research, Xcenda, Palm Harbor, FL, USA...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove Medical Press
2018-08-01
|
| Col·lecció: | ClinicoEconomics and Outcomes Research |
| Matèries: | |
| Accés en línia: | https://www.dovepress.com/relapse-prevention-a-cost-effectiveness-analysis-of-brexpiprazole-trea-peer-reviewed-article-CEOR |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|